SCPH director options converted to cash and CVRs at $5.35 merger price
Rhea-AI Filing Summary
Insider report summary: A Form 4 filed for Abraham William Tober, a director of scPharmaceuticals Inc. (SCPH), discloses cancellation of multiple outstanding stock options and conversion mechanics tied to a merger with MannKind Corporation. On 10/07/2025 the reporting person had three option grants cancelled and treated as dispositions: 30,000, 19,750, and 16,300 option shares. Under the Merger Agreement, Company Options with exercise prices below $5.35 were cancelled and converted into (i) a cash payment equal to the excess of $5.35 over the option exercise price times the number of shares and (ii) one contingent value right per share.
The Form 4 lists the options as disposed (Transaction Code D) on 10/07/2025 and shows 0 shares of common stock resulting from these specific derivative holdings after the transactions.
Positive
- Conversion to cash for in‑the‑money options at $5.35 secures immediate value for option holders
- Contingent Value Rights (CVRs) preserve upside tied to future milestones or payments
Negative
- Cancellation of 66,050 options removes future equity upside from the reporting person
- Post‑transaction holdings show 0 underlying shares from these options, reducing direct stock exposure
Insights
TL;DR: Director's options were cancelled for cash plus CVRs under a merger priced at $5.35.
The cancellation of in‑the‑money options and conversion into a cash payment plus one contingent value right per option share is a standard merger consideration mechanism. This converts potential equity upside into immediate cash value for the option holder and preserves a tied contingent payment through CVRs.
The main dependency is the merger closing and any CVR terms that determine future payments; stakeholders should note the transaction date 10/07/2025 and that the post‑transaction derivative holdings show 0 underlying shares from these grants, removing that equity exposure for the reporting person.
TL;DR: Three option grants totaling 66,050 options were cancelled and treated as dispositions on 10/07/2025.
The Form 4 lists cancellations of options exercisable at $3.85, $4.11, and $4.53, totaling 66,050 option shares. Each cancelled option yields a cash amount equal to the $5.35 merger price less the exercise price multiplied by option count, plus one CVR per share.
Key items to watch are the amount of cash actually paid per cancelled option and the CVR terms and payout triggers, which will determine realized value timing and magnitude after the merger is completed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (Right to Buy) | 30,000 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 19,750 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 16,300 | $0.00 | -- |
Footnotes (1)
- In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the "Merger Agreement"), by and among the Issuer, MannKind Corporation ("Parent") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock ("Common Stock") on October 7, 2025. Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a "Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash, (Continued from footnote 1) without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option.
